Adjuvant chemoradiation for resected gastric cancer: A 10-year experience

Gastric Cancer

Volumn 14, Issue 1, 2011, Pages 63-71

  Chang, Amy T Y ^a   Ng, Wai Tong ^a   Law, Ada L Y ^a   Ku, Ki Man ^a   Lee, Michael C H ^a   Lee, Anne W M ^a  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

Combined modality therapy; Gastrectomy; Gastric neoplasm; Prognosis; Toxicity

Indexed keywords

FLUOROURACIL; FOLINIC ACID; HISTAMINE H2 RECEPTOR ANTAGONIST;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CHEMORADIOTHERAPY; CHINESE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GASTRECTOMY; GASTRITIS; GASTROINTESTINAL TOXICITY; HUMAN; HYPERTENSION; HYPERTRANSAMINASEMIA; INTESTINE OBSTRUCTION; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALABSORPTION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; NEUTROPENIA; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RADIATION DOSE; RECURRENT DISEASE; RETROSPECTIVE STUDY; SIDE EFFECT; STOMACH CANCER; STOMATITIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RECURRENCE; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 79953029882     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-011-0011-y     Document Type: Article

References (33)

1. Hong Kong Cancer Registry. Hong Kong Cancer Stat 2007. Hong Kong: Hospital Authority; 2009.
2. SA Hundahl JL Phillips HR Menck 2000 The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis Cancer 88 921 932 10679663 10.1002/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.0.CO;2-S 1:STN:280:DC%2BD3c7ksFOiuw%3D%3D (Pubitemid 30091113)
3. D Cunningham WH Allum SP Stenning JN Thompson CJ Van de Velde M Nicholson, et al. 2006 Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11 20 16822992 10.1056/NEJMoa055531 1:CAS:528:DC%2BD28Xms1Chsrw%3D
4. S Sakuramoto M Sasako T Yamaguchi T Kinoshita M Fujii A Nashimoto, et al. 2007 Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 1810 1820 17978289 10.1056/NEJMoa072252 1:CAS:528:DC%2BD2sXht1Kit7bI (Pubitemid 350044801)
5. L Gianni I Panzini D Tassinari AM Mianulli F Desiderio A Ravaioli, et al. 2001 Meta-analyses of randomized trials of adjuvant chemotherapy in gastric cancer Ann Oncol 12 1178 1180 11583204 1:STN:280:DC%2BD3MrjsFegtw%3D%3D
6. I Panzini L Gianni PP Fattori D Tassinari M Imola P Fabbri, et al. 2002 Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses Tumori 88 21 27 12004845 1:CAS:528:DC%2BD38Xjt1ChtLo%3D (Pubitemid 34269794)
7. LL Gunderson H Sosin 1982 Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy Int J Radiat Oncol Biol Phys 8 1 11 7061243 1:STN:280:DyaL387ktFOmsw%3D%3D (Pubitemid 12136698)
8. G Klautke R Fietkau 2007 Significance of radiation therapy for adenocarcinomas of the esophagus, gastroesophageal junction and gastric cancer with special reference to the MAGIC trial Strahlenther Onkol 183 163 169 17406796 10.1007/s00066-007-7702-7 (Pubitemid 46570763)
9. F Fiorica F Cartei M Enea A Licata G Cabibbo B Carau, et al. 2007 The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data Cancer Treat Rev 33 729 740 17935888 10.1016/j.ctrv.2007.08.005 (Pubitemid 350082668)
10. V Valentini F Cellini BD Minsky GC Mattiucci M Balducci G D'Agostino, et al. 2009 Survival after radiotherapy in gastric cancer: systematic review and meta-analysis Radiother Oncol 92 176 183 19586672 10.1016/j.radonc.2009.06.014
11. JS Macdonald SR Smalley J Benedetti SA Hundahl NC Estes GN Stemmermann, et al. 2001 Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 725 730 11547741 10.1056/NEJMoa010187 1:STN:280:DC%2BD3Mvps1Cqug%3D%3D
12. SR Smalley L Gunderson J Tepper JA Martenson Jr B Minsky C Willett, et al. 2002 Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation Int J Radiat Oncol Biol Phys 52 283 293 11872272 10.1016/S0360-3016(01)02646-3 (Pubitemid 34170838)
13. J Ringash SJ Khaksart A Oza J Couture B Japp M Moore, et al. 2005 Post-operative radiochemotherapy for gastric cancer: adoption and adaptation Clin Oncol (R Coll Radiol) 17 91 95 1:STN:280:DC%2BD2M7ps12ksQ%3D%3D (Pubitemid 40309885)
14. F De Vita L Vecchione G Galizia N Di Martino T Fabozzi G Catalano, et al. 2009 Perspectives in adjuvant therapy of gastric cancer Oncology 77 Suppl 1 38 42 20130430 10.1159/000258494
15. CC Earle JA Maroun 1999 Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials Eur J Cancer 35 1059 1064 10533448 10.1016/S0959-8049(99) 00076-3 1:STN:280:DC%2BD3c%2FgtlKnsw%3D%3D (Pubitemid 29339187)
16. E Mari I Floriani A Tinazzi A Buda M Belfiglio M Valentini, et al. 2000 Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente) Ann Oncol 11 837 843 10997811 10.1023/A:1008377101672 1:STN:280:DC%2BD3cvks1SgtA%3D%3D
17. KG Janunger L Hafstrom B Glimelius 2002 Chemotherapy in gastric cancer: a review and updated meta-analysis Eur J Surg 168 597 608 12699095 10.1080/11024150201680005 1:CAS:528:DC%2BD3sXjtlelsrs%3D (Pubitemid 36355892)
18. L Lim M Michael GB Mann T Leong 2005 Adjuvant therapy in gastric cancer J Clin Oncol 23 6220 6232 16135489 10.1200/JCO.2005.11.593 1:CAS:528: DC%2BD2MXhtVKgtbrI
19. JS Macdonald 2005 Role of post-operative chemoradiation in resected gastric cancer J Surg Oncol 90 166 170 15895449 10.1002/jso.20223 (Pubitemid 40741181)
20. KS May NI Khushalani R Chandrasekhar GE Wilding RV Iyer WW Ma, et al. 2010 Analysis of clinical and dosimetric factors associated with change in renal function in patients with gastrointestinal malignancies after chemoradiation to the abdomen Int J Radiat Oncol Biol Phys 76 1193 1198 19540051 10.1016/j.ijrobp.2009.03.002
21. EP Jansen MP Saunders H Boot V Oppedijk R Dubbelman B Porritt, et al. 2007 Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer Int J Radiat Oncol Biol Phys 67 781 785 17157445 10.1016/j.ijrobp.2006.09.012 1:CAS:528:DC%2BD2sXhsFKmtLw%3D (Pubitemid 46215865)
22. S Kim DH Lim J Lee WK Kang JS MacDonald CH Park, et al. 2005 An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach Int J Radiat Oncol Biol Phys 63 1279 1285 16099596 10.1016/j.ijrobp.2005.05.005 (Pubitemid 41628018)
23. CN Leong HT Chung KM Lee TP Shakespeare RK Mukherjee LC Wong, et al. 2008 Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma Cancer J 14 269 275 18677137 10.1097/PPO.0b013e318178d23a 1:CAS:528:DC%2BD1cXhtF2jsLjI
24. M Moehler O Lyros I Gockel PR Galle H Lang 2008 Multidisciplinary management of gastric and gastroesophageal cancers World J Gastroenterol 14 3773 3780 18609699 10.3748/wjg.14.3773
25. K Maruyama M Sasako T Kinoshita T Sano H Katai M Hada, et al. 1998 Should systematic lymph node dissection be recommended for gastric cancer? Eur J Cancer 34 1480 1489 9893618 10.1016/S0959-8049(98)00201-9 1:STN:280: DyaK1M7gvFCqtA%3D%3D (Pubitemid 28446326)
26. M Degiuli M Sasako M Calgaro M Garino F Rebecchi M Mineccia, et al. 2004 Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial Eur J Surg Oncol 30 303 308 15028313 1:STN:280:DC%2BD2c7jsFOhsQ%3D%3D (Pubitemid 38425649)
27. Lee J, Kang W, Lim D, et al. Phase III trial of adjuvant capecitabine/cisplatin (XP) versus capecitabine/cisplatin/RT (XPRT) in resected gastric cancer with D2 nodal dissection (ARTIST trial): safety analysis. J Clin Oncol 2009;27(15 Suppl):abstr 4537.
28. J Ringash G Perkins J Brierley G Lockwood M Islam P Catton, et al. 2005 IMRT for adjuvant radiation in gastric cancer: a preferred plan? Int J Radiat Oncol Biol Phys 63 732 738 15978742 10.1016/j.ijrobp.2005.03.013 (Pubitemid 41400059)
29. P Wieland B Dobler S Mai B Hermann U Tiefenbacher V Steil, et al. 2004 IMRT for postoperative treatment of gastric cancer: covering large target volumes in the upper abdomen: a comparison of a step-and-shoot and an arc therapy approach Int J Radiat Oncol Biol Phys 59 1236 1244 15234061 10.1016/j.ijrobp.2004.02.051 (Pubitemid 38834320)
30. MT Milano MC Garofalo SJ Chmura K Farrey C Rash R Heimann, et al. 2006 Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniques Br J Radiol 79 497 503 16714752 10.1259/bjr/43441736 1:STN:280:DC%2BD283ot1yisg%3D%3D (Pubitemid 43933447)
31. B Wysocka Z Kassam G Lockwood J Brierley LA Dawson CA Buckley, et al. 2010 Interfraction and respiratory organ motion during conformal radiotherapy in gastric cancer Int J Radiat Oncol Biol Phys 77 53 59 19665320 10.1016/j.ijrobp.2009.04.046
32. Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS). http://www.clinicaltrial.gov/ct2/show/ NCT00407186?term=CRITICS&rank=3.
33. Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer (CALGB80101). http://www.clinicaltrial.gov/ ct2/show/NCT00052910?term=CALGB80101&rank=1.